Thomas Gonsch

Suggest Changes
Learn More
PURPOSE The oral fluoropyrimidine carbamate, capecitabine, is a highly active and well-tolerated treatment for metastatic breast cancer. In patients treated previously with anthracyclines and(More)
  • 1